Injex Pharma Given China Approval for Needle-Free Delivery Device

Published: Apr 17, 2013

by Richard Daverman, PhD

April 17, 2103 -- Injex Pharma of Germany was granted SFDA approval to market its INJEX30 needle-free injection system in China. Injex said its exclusive China distributor, Hangzhou Hema Medical Equipment Co., helped with the one and one-half year registration process, which it described as “arduous.” Injex will sell the product as a needle-free delivery system for insulin. More details....

Back to news